Clinical Trials Browser

Pathologic Complete Response

Locally Advanced Rectal Cancer

HER2-positive Breast Cancer

Breast Neoplasms

Nasopharyngeal Carcinoma

Resectable Colon Cancer

Breast Neoplasms

Rectal Neoplasms

Breast Neoplasms, Recurrence

Breast Neoplasms, Triple Negative Breast Neoplasms

Advanced Solid Tumour

Adenocarcinoma

Rectal Neoplasms Malignant

Locally Advanced Rectal Cancer (LARC)

Colorectal Neoplasms

Breast Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

HER2-positive Gastric Cancer

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Nasopharyngeal Carcinoma

Colorectal Neoplasms

Carcinoma, Hepatocellular

Cholangiocarcinoma

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Locally Advanced Low Rectal Adenocarcinoma

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Colorectal Neoplasms

Nasopharyngeal Cancinoma (NPC)

Rectal Neoplasms

Esophageal Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Stomach Neoplasms

CLDN18.2-positive Advanced Biliary Tract Cancer

Colonic Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Adenocarcinoma

Rectal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms, Recurrence

Pancreatic Cancer Resectable

Clinical Trials

MEND-IT II

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

BREnnA

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer

EVOLVE-BDT

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer

IMMUNOSTAR

Neo-CD

BRIGHT

ARIEL-ENGIC

CIRCULATEIII

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Cocktail-001

Adjuvant Chemotherapy for BTC Based on 3D-PTA

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

CAPTURE

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

EC-CRT-008

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer

Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.